# Prevention of Allergic Diseases in Infants

> **NCT03489733** · NA · COMPLETED · sponsor: **HiPP GmbH & Co. Vertrieb KG** · enrollment: 1226 (actual)

## Conditions studied

- Atopic Diseases

## Interventions

- **OTHER:** Hydrolyzed Formula
- **OTHER:** Control formula

## Key facts

- **NCT ID:** NCT03489733
- **Lead sponsor:** HiPP GmbH & Co. Vertrieb KG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-09
- **Primary completion:** 2021-03-31
- **Final completion:** 2025-10-30
- **Target enrollment:** 1226 (ACTUAL)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03489733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03489733, "Prevention of Allergic Diseases in Infants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03489733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*